Relay Therapeutics, Inc. (RLAY) insider activity

Relay Therapeutics, Inc. (RLAY): 0 insider buys and 3 sales reported in the last 90 days.

A top executive sold $14,021 of Relay Therapeutics, Inc. stock. People sell for many reasons (taxes, a house, diversifying), so a sale means far less than a purchase. (2026-10-30)
The CEO sold $41,932 of Relay Therapeutics, Inc. stock. People sell for many reasons (taxes, a house, diversifying), so a sale means far less than a purchase. (2026-10-30)
The CFO sold $27,353 of Relay Therapeutics, Inc. stock. People sell for many reasons (taxes, a house, diversifying), so a sale means far less than a purchase. (2026-10-30)

Reported	Who	Stock	What	Amount	Source
2026-10-30	Rahmer Peter See remarks	RLAY Relay Therapeutics, Inc.	Sold	$14,021	SEC filing
2026-10-30	Bergstrom Donald A President, R&D	RLAY Relay Therapeutics, Inc.	Sold	$41,932	SEC filing
2026-10-30	Catinazzo Thomas Chief Financial Officer	RLAY Relay Therapeutics, Inc.	Sold	$27,353	SEC filing

All insider buys · Legends

TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.